Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV003411340 | SCV004139243 | benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | COX6A2: BS1, BS2 |
Mayo Clinic Laboratories, |
RCV003411340 | SCV005411301 | uncertain significance | not provided | 2023-12-19 | criteria provided, single submitter | clinical testing | BP4 |
Prevention |
RCV003929070 | SCV004739712 | likely benign | COX6A2-related disorder | 2022-05-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |